Developing an eLearning Program in Helping Spanish and Portuguese Speaking Cancer Care Providers During Tobacco Use Counselling
SWOG Tobacco Program for the Oncology Practice
2 other identifiers
interventional
89
3 countries
3
Brief Summary
This trial aims to develop an electronic learning (eLearning) program and mobile tool for Spanish and Portuguese speaking cancer care providers to use in tobacco counseling of their patients. This study may provide information for the design and implementation of tobacco cessation training programs directed to this group of professionals in low- and middle-income countries for the Latin American region.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 18, 2018
CompletedFirst Submitted
Initial submission to the registry
May 16, 2018
CompletedFirst Posted
Study publicly available on registry
May 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 17, 2021
CompletedSeptember 5, 2021
September 1, 2021
3.3 years
May 16, 2018
September 3, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Recruitment and retention rates
Will be used as key parameters for assessing the feasibility of the eLearning program. The Wilcoxon signed-rank test will be used to compare scores obtained in the pre- and post-tests of the eLearning program. Effect sizes will be computed as the absolute value of the difference between the post-test (T2, T3, and T4) and pre-test (T1) scores divided by the mean of the standard deviations for each.
Up to 6 months
Linguistically/culturally tailored mobile tool
Computing the System Usability Scale (SUS) scores in the final assessment will allow our research team to analyze cancer care provider's (CCPs) experience of using the tool. A descriptive analysis to compute the SUS score will be performed and later converted to percentile ranks. A percentile rank of 75% will indicate that the tool has high perceived usability. All statistical analyses will be performed using SPSS Statistics version 23 (International Business Machines Corporation).
Up to 6 months
Other Outcomes (1)
Gains in participants' competencies in providing smoking cessation assistance to cancer patients
Baseline up to 6 months
Study Arms (1)
Supportive care (online course, virtual meeting)
EXPERIMENTALParticipants complete an online course focusing on different aspects of tobacco prevention and cessation over 1 hour each per week for 4 weeks. They also engage in 6 virtual meetings over 1 hour about tobacco use once per month.
Interventions
Complete online courses
Eligibility Criteria
You may qualify if:
- Be a cancer care provider (CCP) working at one of the above cancer centers
- Have direct contact with cancer patients
- Have access to the internet during the 4-hour online course and at least once per month to participate in post-training virtual meetings, discussion board postings, email, and periodic audio chat conferences
- Have access to a computer, tablet, or smartphone (iPhone or Android) with built-in camera and microphone
- Have basic proficiency in the use of a computer, including word processing and email
- Commit to the STOP Program by completing the online course and sharing lessons learned with other CCPs at the monthly virtual meetings that will take place during the 6 months following course completion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (3)
Hosptial de Cancer de Barretos
Barretos, São Paulo, 14784, Brazil
Instituto Nacional De Cancerologia
Bogotá, 99999, Colombia
Instituto Nacional de Enfermedades Neoplasicas
Lima, Lima 34, Peru
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Peterson
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2018
First Posted
May 30, 2018
Study Start
April 18, 2018
Primary Completion
August 17, 2021
Study Completion
August 17, 2021
Last Updated
September 5, 2021
Record last verified: 2021-09